Control Bionics Limited (CBL.AX)
AUD 0.06
(-1.69%)
AUD 0.06
(-1.69%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 404.15 Thousand AUD | -49.6% |
| 2023 | 801.9 Thousand AUD | -13.21% |
| 2022 | 923.96 Thousand AUD | 243.0% |
| 2021 | 269.37 Thousand AUD | 50.49% |
| 2020 | 179 Thousand AUD | -0.81% |
| 2019 | 180.45 Thousand AUD | 105.17% |
| 2018 | 87.95 Thousand AUD | 0.0% |
| 2017 | - NZD | 0.0% |
| 2016 | - NZD | 0.0% |
| 2015 | - NZD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 404.15 Thousand AUD | -22.01% |
| 2024 Q2 | 518.21 Thousand AUD | 0.0% |
| 2024 Q4 | 404.15 Thousand AUD | 0.0% |
| 2024 FY | 404.15 Thousand AUD | -49.6% |
| 2024 Q1 | 518.21 Thousand AUD | -35.38% |
| 2023 Q2 | 1.01 Million AUD | 0.0% |
| 2023 Q4 | 801.9 Thousand AUD | 0.0% |
| 2023 FY | 801.9 Thousand AUD | -13.21% |
| 2023 Q3 | 801.9 Thousand AUD | -20.71% |
| 2023 Q1 | 1.01 Million AUD | 9.46% |
| 2022 FY | 923.96 Thousand AUD | 243.0% |
| 2022 Q4 | 923.96 Thousand AUD | -0.0% |
| 2022 Q3 | 923.96 Thousand AUD | 62.27% |
| 2022 Q2 | 569.41 Thousand AUD | 0.0% |
| 2022 Q1 | 569.41 Thousand AUD | 111.38% |
| 2021 Q1 | - AUD | -100.0% |
| 2021 FY | 269.37 Thousand AUD | 50.49% |
| 2021 Q4 | 269.37 Thousand AUD | 0.0% |
| 2021 Q3 | 269.37 Thousand AUD | -8.66% |
| 2021 Q2 | 294.91 Thousand AUD | 0.0% |
| 2020 Q4 | 179.33 Thousand AUD | 0.0% |
| 2020 FY | 179 Thousand AUD | -0.81% |
| 2019 FY | 180.45 Thousand AUD | 105.17% |
| 2018 FY | 87.95 Thousand AUD | 0.0% |
| 2017 FY | - NZD | 0.0% |
| 2017 Q2 | - NZD | 0.0% |
| 2016 FY | - NZD | 0.0% |
| 2015 FY | - NZD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| 4DMedical Limited | 992.24 Thousand AUD | 59.269% |
| Adherium Limited | 1.58 Million AUD | 74.458% |
| Aroa Biosurgery Limited | 7.43 Million AUD | 94.561% |
| Atomo Diagnostics Limited | 1.83 Million AUD | 78.02% |
| Anteris Technologies Ltd | 646.71 Thousand AUD | 37.507% |
| CardieX Limited | 2.55 Million AUD | 84.173% |
| Compumedics Limited | 13.21 Million AUD | 96.941% |
| Cochlear Limited | 391.6 Million AUD | 99.897% |
| CleanSpace Holdings Limited | 2.86 Million AUD | 85.896% |
| Cyclopharm Limited | 10.12 Million AUD | 96.007% |
| EMVision Medical Devices Ltd | - AUD | -Infinity% |
| Nova Eye Medical Limited | 4.28 Million AUD | 90.564% |
| HeraMED Limited | 361.61 Thousand AUD | -11.763% |
| Imricor Medical Systems, Inc. | 2.46 Million AUD | 83.598% |
| ImpediMed Limited | 759 Thousand AUD | 46.752% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.61 Million AUD | 75.022% |
| Micro-X Limited | 5.37 Million AUD | 92.487% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 391.67 Thousand AUD | -3.186% |
| PolyNovo Limited | 8.97 Million AUD | 95.495% |
| Respiri Limited | 2.75 Million AUD | 85.312% |
| SomnoMed Limited | 6.28 Million AUD | 93.57% |
| Universal Biosensors, Inc. | 4.37 Million AUD | 90.768% |
| Uscom Limited | 623.62 Thousand AUD | 35.194% |
| Visioneering Technologies, Inc. | 3.16 Million AUD | 87.239% |